{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:30:11Z","timestamp":1792693811633,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jfma.2022.05.005","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T09:15:07Z","timestamp":1654593307000},"page":"2490-2500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Efficacy of atropine, orthokeratology, and combined atropine with orthokeratology for childhood myopia: A systematic review and network meta-analysis"],"prefix":"10.1016","volume":"121","author":[{"given":"Hou-Ren","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4946-8064","authenticated-orcid":false,"given":"Jen-Hung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huei-Kai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5761-8114","authenticated-orcid":false,"given":"Tai-Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4004-5823","authenticated-orcid":false,"given":"Cheng-Jen","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7543","key":"10.1016\/j.jfma.2022.05.005_bib1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/519276a","article-title":"The myopia boom","volume":"519","author":"Dolgin","year":"2015","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.jfma.2022.05.005_bib2","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2471\/BLT.12.104034","article-title":"Global cost of correcting vision impairment from uncorrected refractive error","volume":"90","author":"Fricke","year":"2012","journal-title":"Bull World Health Organ"},{"issue":"9","key":"10.1016\/j.jfma.2022.05.005_bib3","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1167\/iovs.12-10106","article-title":"Prevalence of myopia and its association with body stature and educational level in 19-year-old male conscripts in seoul, South Korea","volume":"53","author":"Jung","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Suppl 1","key":"10.1016\/j.jfma.2022.05.005_bib4","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/S0039-6257(99)00094-6","article-title":"Prevalence of myopia and refractive changes in students from 3 to 17 years of age","volume":"44","author":"Matsumura","year":"1999","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"10.1016\/j.jfma.2022.05.005_bib5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/00006324-200104000-00012","article-title":"Does education explain ethnic differences in myopia prevalence? A population-based study of young adult males in Singapore","volume":"78","author":"Wu","year":"2001","journal-title":"Optom Vis Sci"},{"issue":"12","key":"10.1016\/j.jfma.2022.05.005_bib6","doi-asserted-by":"crossref","first-page":"e82763","DOI":"10.1371\/journal.pone.0082763","article-title":"Refractive error, visual acuity and causes of vision loss in children in Shandong, China. The Shandong Children Eye Study","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jfma.2022.05.005_bib7","doi-asserted-by":"crossref","first-page":"e0120764","DOI":"10.1371\/journal.pone.0120764","article-title":"Prevalence and associated factors of myopia in high-school students in Beijing","volume":"10","author":"Wu","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jfma.2022.05.005_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1475-1313.2011.00884.x","article-title":"Worldwide prevalence and risk factors for myopia","volume":"32","author":"Pan","year":"2012","journal-title":"Ophthalmic Physiol Opt"},{"issue":"1","key":"10.1016\/j.jfma.2022.05.005_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2004.06.004","article-title":"How genetic is school myopia?","volume":"24","author":"Morgan","year":"2005","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"10.1016\/j.jfma.2022.05.005_bib10","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050","volume":"123","author":"Holden","year":"2016","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.jfma.2022.05.005_bib11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.exer.2005.08.009","article-title":"The sclera and myopia","volume":"82","author":"Rada","year":"2006","journal-title":"Exp Eye Res"},{"issue":"5","key":"10.1016\/j.jfma.2022.05.005_bib12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0002-9394(02)01883-4","article-title":"Pathologic myopia: where are we now?","volume":"134","author":"Tano","year":"2002","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jfma.2022.05.005_bib13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1475-1313.2005.00298.x","article-title":"Myopia and associated pathological complications","volume":"25","author":"Saw","year":"2005","journal-title":"Ophthalmic Physiol Opt"},{"issue":"5","key":"10.1016\/j.jfma.2022.05.005_bib14","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/bjo.2005.087999","article-title":"How blinding is pathological myopia?","volume":"90","author":"Saw","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"10.1016\/j.jfma.2022.05.005_bib15","first-page":"1482","article-title":"Review: myopia control strategies recommendations from the 2018 WHO\/IAPB\/BHVI meeting on myopia","volume":"104","author":"Ang","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jfma.2022.05.005_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clae.2019.11.002","article-title":"Global trends in myopia management attitudes and strategies in clinical practice - 2019 Update","volume":"43","author":"Wolffsohn","year":"2020","journal-title":"Contact Lens Anterior Eye"},{"key":"10.1016\/j.jfma.2022.05.005_bib17","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1159\/000510779","article-title":"Combined orthokeratology with atropine for children with myopia: a meta-analysis","volume":"64(5)","author":"Wang","year":"2021","journal-title":"Ophthalmic Res"},{"issue":"1","key":"10.1016\/j.jfma.2022.05.005_bib18","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1186\/s12886-020-01746-w","article-title":"Efficacy and safety of atropine to control myopia progression: a systematic review and meta-analysis","volume":"20","author":"Zhao","year":"2020","journal-title":"BMC Ophthalmol"},{"issue":"6","key":"10.1016\/j.jfma.2022.05.005_bib19","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1001\/jamaophthalmol.2017.1091","article-title":"Efficacy and adverse effects of atropine in childhood myopia: a meta-analysis","volume":"135","author":"Gong","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"10.1016\/j.jfma.2022.05.005_bib20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/jop.2011.0017","article-title":"Atropine in ameliorating the progression of myopia in children with mild to moderate myopia: a meta-analysis of controlled clinical trials","volume":"27","author":"Song","year":"2011","journal-title":"J Ocul Pharmacol Therapeut"},{"issue":"5","key":"10.1016\/j.jfma.2022.05.005_bib21","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3109\/02713683.2015.1050743","article-title":"Efficacy, safety and acceptability of orthokeratology on slowing axial elongation in myopic children by meta-analysis","volume":"41","author":"Li","year":"2016","journal-title":"Curr Eye Res"},{"issue":"3","key":"10.1016\/j.jfma.2022.05.005_bib22","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/OPX.0000000000000505","article-title":"Orthokeratology for myopia control: a meta-analysis","volume":"92","author":"Si","year":"2015","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.jfma.2022.05.005_bib23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2415-14-40","article-title":"Overnight orthokeratology is comparable with atropine in controlling myopia","volume":"14","author":"Lin","year":"2014","journal-title":"BMC Ophthalmol"},{"issue":"2","key":"10.1016\/j.jfma.2022.05.005_bib24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/ICL.0000000000000699","article-title":"Comparison of administration of 0.02% atropine and orthokeratology for myopia control","volume":"47","author":"Lyu","year":"2021","journal-title":"Eye Contact Lens"},{"issue":"2","key":"10.1016\/j.jfma.2022.05.005_bib25","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/ICL.0000000000000746","article-title":"The efficacy of atropine combined with orthokeratology in slowing axial elongation of myopia children: a meta-analysis","volume":"47","author":"Gao","year":"2021","journal-title":"Eye Contact Lens"},{"issue":"4","key":"10.1016\/j.jfma.2022.05.005_bib26","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ophtha.2018.11.026","article-title":"Use of orthokeratology for the prevention of myopic progression in children: a report by the American academy of ophthalmology","volume":"126","author":"VanderVeen","year":"2019","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.jfma.2022.05.005_bib27","first-page":"Cd004916","article-title":"Interventions to slow progression of myopia in children","volume":"1","author":"Walline","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.jfma.2022.05.005_bib28","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ophtha.2015.11.010","article-title":"Efficacy comparison of 16 interventions for myopia control in children: a network meta-analysis","volume":"123","author":"Huang","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfma.2022.05.005_bib29","series-title":"Cochrane handbook for systematic reviews of interventions version 6.2 (updated february 2021). Cochrane","year":"2021"},{"key":"10.1016\/j.jfma.2022.05.005_bib30","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.jfma.2022.05.005_bib31","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1177\/1536867X1501500403","article-title":"Network meta-analysis","volume":"15","author":"White","year":"2015","journal-title":"STATA J"},{"issue":"2","key":"10.1016\/j.jfma.2022.05.005_bib32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jrsm.1045","article-title":"Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression","volume":"3","author":"White","year":"2012","journal-title":"Res Synth Methods"},{"issue":"474","key":"10.1016\/j.jfma.2022.05.005_bib33","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1198\/016214505000001302","article-title":"Assessing evidence inconsistency in mixed treatment comparisons","volume":"101","author":"Lu","year":"2006","journal-title":"J Am Stat Assoc"},{"issue":"2","key":"10.1016\/j.jfma.2022.05.005_bib34","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies","volume":"3","author":"Higgins","year":"2012","journal-title":"Res Synth Methods"},{"issue":"2","key":"10.1016\/j.jfma.2022.05.005_bib35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.jfma.2022.05.005_bib36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/jop.1999.15.85","article-title":"Effects of different concentrations of atropine on controlling myopia in myopic children","volume":"15","author":"Shih","year":"1999","journal-title":"J Ocul Pharmacol Therapeut"},{"issue":"1","key":"10.1016\/j.jfma.2022.05.005_bib37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","article-title":"Low-concentration atropine for myopia progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control","volume":"126","author":"Yam","year":"2019","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.jfma.2022.05.005_bib38","first-page":"1535","article-title":"Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude: low-dose atropine and myopia progression","volume":"104","author":"Fu","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jfma.2022.05.005_bib39","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","article-title":"Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2)","volume":"119","author":"Chia","year":"2012","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.jfma.2022.05.005_bib40","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/OPX.0b013e318293657d","article-title":"High myopia-partial reduction ortho-k: a 2-year randomized study","volume":"90","author":"Charm","year":"2013","journal-title":"Optom Vis Sci"},{"issue":"11","key":"10.1016\/j.jfma.2022.05.005_bib41","doi-asserted-by":"crossref","first-page":"7077","DOI":"10.1167\/iovs.12-10565","article-title":"Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial","volume":"53","author":"Cho","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.jfma.2022.05.005_bib42","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.ophtha.2006.05.062","article-title":"Atropine for the treatment of childhood myopia","volume":"113","author":"Chua","year":"2006","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.jfma.2022.05.005_bib43","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10384-021-00822-y","article-title":"Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study","volume":"65","author":"Hieda","year":"2021","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jfma.2022.05.005_bib44","doi-asserted-by":"crossref","first-page":"12750","DOI":"10.1038\/s41598-020-69710-8","article-title":"Efficacy of combined orthokeratology and 0.01% atropine solution for slowing axial elongation in children with myopia: a 2-year randomised trial","volume":"10","author":"Kinoshita","year":"2020","journal-title":"Sci Rep"},{"issue":"21","key":"10.1016\/j.jfma.2022.05.005_bib45","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1002\/sim.2211","article-title":"Inference of nested variance components in a longitudinal myopia intervention trial","volume":"24","author":"Hsiao","year":"2005","journal-title":"Stat Med"},{"issue":"3","key":"10.1016\/j.jfma.2022.05.005_bib46","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1034\/j.1600-0420.2001.790304.x","article-title":"An intervention trial on efficacy of atropine and multi-focal glasses in controlling myopic progression","volume":"79","author":"Shih","year":"2001","journal-title":"Acta Ophthalmol Scand"},{"issue":"5","key":"10.1016\/j.jfma.2022.05.005_bib47","first-page":"180","article-title":"Comparison of the effect of atropine and cyclopentolate on myopia","volume":"21","author":"Yen","year":"1989","journal-title":"Ann Ophthalmol"},{"key":"10.1016\/j.jfma.2022.05.005_bib48","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.ophtha.2021.01.026","article-title":"Atropine for the treatment of childhood myopia in India: multicentric randomized trial","volume":"128(9)","author":"Saxena","year":"2021","journal-title":"Ophthalmology"},{"issue":"27","key":"10.1016\/j.jfma.2022.05.005_bib49","doi-asserted-by":"crossref","first-page":"e7371","DOI":"10.1097\/MD.0000000000007371","article-title":"Atropine 0.5% eyedrops for the treatment of children with low myopia: a randomized controlled trial","volume":"96","author":"Wang","year":"2017","journal-title":"Medicine (Baltim)"},{"issue":"11","key":"10.1016\/j.jfma.2022.05.005_bib50","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/jamaophthalmol.2020.3820","article-title":"Safety and efficacy of low-dose atropine eyedrops for the treatment of myopia progression in Chinese children: a randomized clinical trial","volume":"138","author":"Wei","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"10.1016\/j.jfma.2022.05.005_bib51","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jaapos.2015.04.006","article-title":"Therapeutic effect of atropine 1% in children with low myopia","volume":"19","author":"Yi","year":"2015","journal-title":"J aapos"},{"key":"10.1016\/j.jfma.2022.05.005_bib52","first-page":"1","article-title":"Comparison of the clinical efficacies of 0.01% atropine and orthokeratology in controlling the progression of myopia in children","author":"Zhao","year":"2021","journal-title":"Ophthalmic Epidemiol"},{"issue":"5","key":"10.1016\/j.jfma.2022.05.005_bib53","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/opo.12722","article-title":"One-year results of 0.01% atropine with orthokeratology (AOK) study: a randomised clinical trial","volume":"40","author":"Tan","year":"2020","journal-title":"Ophthalmic Physiol Opt"},{"issue":"7","key":"10.1016\/j.jfma.2022.05.005_bib54","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ophtha.2019.12.011","article-title":"Two-year clinical trial of the low-concentration atropine for myopia progression (LAMP) study: phase 2 report","volume":"127","author":"Yam","year":"2020","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.jfma.2022.05.005_bib55","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ophtha.2021.10.002","article-title":"Three-year clinical trial of low-concentration atropine for myopia progression (LAMP) study: continued versus washout: phase 3 report","volume":"129","author":"Yam","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfma.2022.05.005_bib56","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ajo.2021.12.014","article-title":"The Association of Choroidal Thickening by Atropine With Treatment Effects for Myopia: Two-Year Clinical Trial of the Low-concentration Atropine for Myopia Progression (LAMP) Study","volume":"237","author":"Yam","year":"2022","journal-title":"American Journal of Ophthalmology"},{"issue":"6","key":"10.1016\/j.jfma.2022.05.005_bib57","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s10792-021-01755-8","article-title":"Side effects of topical atropine 0.05% compared to 0.01% for myopia control in German school children: a pilot study","volume":"41","author":"Joachimsen","year":"2021","journal-title":"Int Ophthalmol"},{"issue":"7","key":"10.1016\/j.jfma.2022.05.005_bib58","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/eye.2016.78","article-title":"Effectiveness study of atropine for progressive myopia in Europeans","volume":"30","author":"Polling","year":"2016","journal-title":"Eye"},{"issue":"12","key":"10.1016\/j.jfma.2022.05.005_bib59","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.ophtha.2017.05.032","article-title":"Atropine for the prevention of myopia progression in children: a report by the American academy of ophthalmology","volume":"124","author":"Pineles","year":"2017","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.jfma.2022.05.005_bib60","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1007\/s00417-018-4078-6","article-title":"Current trends among pediatric ophthalmologists to decrease myopia progression-an international perspective","volume":"256","author":"Zloto","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"17","key":"10.1016\/j.jfma.2022.05.005_bib61","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.3390\/jcm10173766","article-title":"Is 0.01% atropine an effective and safe treatment for myopic children? A systemic review and meta-analysis","volume":"10","author":"Tsai","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jfma.2022.05.005_bib62","first-page":"221","article-title":"Low concentration atropine combined with orthokeratology in the treatment of axial elongation in children with myopia: a meta-analysis","volume":"32(1)","author":"Yang","year":"2021","journal-title":"Eur J Ophthalmol"},{"issue":"9","key":"10.1016\/j.jfma.2022.05.005_bib63","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3390\/jcm7090259","article-title":"The synergistic effects of orthokeratology and atropine in slowing the progression of myopia","volume":"7","author":"Wan","year":"2018","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.jfma.2022.05.005_bib64","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/opo.12730","article-title":"Higher order aberrations and axial elongation in combined 0.01% atropine with orthokeratology for myopia control","volume":"40","author":"Vincent","year":"2020","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.jfma.2022.05.005_bib65","doi-asserted-by":"crossref","first-page":"34936","DOI":"10.1038\/srep34936","article-title":"The effect of topical atropine on the choroidal thickness of healthy children","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.jfma.2022.05.005_bib66","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1097\/OPX.0000000000000894","article-title":"Effects of orthokeratology on choroidal thickness and axial length","volume":"93","author":"Chen","year":"2016","journal-title":"Optom Vis Sci"},{"issue":"6","key":"10.1016\/j.jfma.2022.05.005_bib67","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.clae.2017.09.010","article-title":"Choroidal thickness and axial length changes in myopic children treated with orthokeratology","volume":"40","author":"Li","year":"2017","journal-title":"Contact Lens Anterior Eye"},{"issue":"3","key":"10.1016\/j.jfma.2022.05.005_bib68","doi-asserted-by":"crossref","first-page":"e454","DOI":"10.1111\/aos.13866","article-title":"Change in subfoveal choroidal thickness secondary to orthokeratology and its cessation: a predictor for the change in axial length","volume":"97","author":"Li","year":"2019","journal-title":"Acta Ophthalmol"},{"issue":"9","key":"10.1016\/j.jfma.2022.05.005_bib69","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1007\/s10792-021-01855-5","article-title":"Changes in subfoveal choroidal thickness in myopic children with 0.01% atropine, orthokeratology, or their combination","volume":"41","author":"Hao","year":"2021","journal-title":"Int Ophthalmol"},{"issue":"1","key":"10.1016\/j.jfma.2022.05.005_bib70","doi-asserted-by":"crossref","first-page":"17344","DOI":"10.1038\/s41598-021-96698-6","article-title":"Stepwise low concentration atropine for myopic control: a 10-year cohort study","volume":"11","author":"Chuang","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.jfma.2022.05.005_bib71","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/OPX.0000000000000178","article-title":"Atropine slows myopia progression more in Asian than white children by meta-analysis","volume":"91","author":"Li","year":"2014","journal-title":"Optom Vis Sci"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664622002108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664622002108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:48:34Z","timestamp":1760539714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664622002108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":71,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0929664622002108"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2022.05.005","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of atropine, orthokeratology, and combined atropine with orthokeratology for childhood myopia: A systematic review and network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2022.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}